1. Home
  2. SHC vs GH Comparison

SHC vs GH Comparison

Compare SHC & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sotera Health Company

SHC

Sotera Health Company

HOLD

Current Price

$18.73

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$178.92

Market Cap

22.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHC
GH
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
22.9B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
SHC
GH
Price
$18.73
$178.92
Analyst Decision
Buy
Strong Buy
Analyst Count
7
19
Target Price
$20.33
$119.79
AVG Volume (30 Days)
1.8M
1.7M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
68.75
6.74
EPS
0.28
N/A
Revenue
$1,163,617,000.00
$982,021,000.00
Revenue This Year
$7.51
$33.30
Revenue Next Year
$6.00
$28.27
P/E Ratio
$67.68
N/A
Revenue Growth
5.74
32.88
52 Week Low
$13.09
$55.38
52 Week High
$19.85
$183.51

Technical Indicators

Market Signals
Indicator
SHC
GH
Relative Strength Index (RSI) 50.94 62.09
Support Level $18.20 $153.88
Resistance Level $19.79 N/A
Average True Range (ATR) 0.43 8.48
MACD -0.03 1.69
Stochastic Oscillator 48.47 83.84

Price Performance

Historical Comparison
SHC
GH

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: